![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 32, 29304-29314, August 9, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Departments of Activation of signal transduction kinase
cascades has been shown to alter androgen receptor (AR) activity.
Although it has been suggested that changes in AR phosphorylation might
be directly responsible, the basal and regulated phosphorylations of
the AR have not been fully determined. We have identified the major
sites of AR phosphorylation on ARs expressed in COS-1 cells using a combination of peptide mapping, Edman degradation, and mass
spectrometry. We describe the identification of seven AR
phosphorylation sites, show that the phosphopeptides seen with
exogenously expressed ARs are highly similar to those seen with
endogenous ARs in LNCaP cells and show that specific agonists
differentially regulate the phosphorylation state of endogenous ARs in
LNCaP prostate cancer cells. Treatment of LNCaP cells with the
synthetic androgen, R1881, elevates phosphorylation of serines 16, 81, 256, 308, 424, and 650. Ser-94 appears constitutively phosphorylated.
Forskolin, epidermal growth factor, and phorbol 12-myristate 13-acetate
increase the phosphorylation of Ser-650. The kinetics of
phosphorylation of most sites in response to hormone or forskolin is
temporally delayed, reaching a maximum at 2 h post-stimulation.
The exception is Ser-81, which continues to display increasing
phosphorylation at 6 h. These data provide a basis for analyzing
mechanisms of cross-talk between growth factor signaling and androgen
in prostate development, physiology, and cancer.
Androgen Receptor Phosphorylation
REGULATION AND IDENTIFICATION OF THE PHOSPHORYLATION SITES*
§,
,
,
,
,

Microbiology and Cancer
Center, ** Pathology, ¶ Chemistry, and
Pharmacology and Molecular Medicine Program, University of
Virginia Health Sciences Center, Charlottesville, Virginia 22908
*
This work was supported by a gift from CaP CURE,
a grant from the Mellon Prostate Cancer Research Institute at the
University of Virginia, and United States Public Health Service Grants
CA39076, CA76465, CA40042 (to M. J. W.), and GM37537 (to D. F. H.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.

To whom correspondence should be addressed. Tel.: 434-924-5052;
Fax: 434-982-0689; E-mail: MJW@Virginia.edu.
This article has been cited by other articles:
![]() |
M. M. Centenera, J. M. Harris, W. D. Tilley, and L. M. Butler Minireview: The Contribution of Different Androgen Receptor Domains to Receptor Dimerization and Signaling Mol. Endocrinol., November 1, 2008; 22(11): 2373 - 2382. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. U. Agoulnik, W. E. Bingman III, M. Nakka, W. Li, Q. Wang, X. S. Liu, M. Brown, and N. L. Weigel Target Gene-Specific Regulation of Androgen Receptor Activity by p42/p44 Mitogen-Activated Protein Kinase Mol. Endocrinol., November 1, 2008; 22(11): 2420 - 2432. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Ponguta, C. W. Gregory, F. S. French, and E. M. Wilson Site-specific Androgen Receptor Serine Phosphorylation Linked to Epidermal Growth Factor-dependent Growth of Castration-recurrent Prostate Cancer J. Biol. Chem., July 25, 2008; 283(30): 20989 - 21001. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kaulfuss, M. Grzmil, B. Hemmerlein, P. Thelen, S. Schweyer, J. Neesen, L. Bubendorf, A. G. Glass, H. Jarry, B. Auber, et al. Leupaxin, a Novel Coactivator of the Androgen Receptor, Is Expressed in Prostate Cancer and Plays a Role in Adhesion and Invasion of Prostate Carcinoma Cells Mol. Endocrinol., July 1, 2008; 22(7): 1606 - 1621. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Seaton, P. Scullin, P. J. Maxwell, C. Wilson, J. Pettigrew, R. Gallagher, J. M. O'Sullivan, P. G. Johnston, and D. J. J. Waugh Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activation Carcinogenesis, June 1, 2008; 29(6): 1148 - 1156. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Miyajima, S. Maruyama, M. Bohgaki, S. Kano, M. Shigemura, N. Shinohara, K. Nonomura, and S. Hatakeyama TRIM68 Regulates Ligand-Dependent Transcription of Androgen Receptor in Prostate Cancer Cells Cancer Res., May 1, 2008; 68(9): 3486 - 3494. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Shank, J. B. Kelley, D. Gioeli, C.-S. Yang, A. Spencer, L. A. Allison, and B. M. Paschal Activation of the DNA-dependent Protein Kinase Stimulates Nuclear Export of the Androgen Receptor in Vitro J. Biol. Chem., April 18, 2008; 283(16): 10568 - 10580. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chen, K. C. Ahn, N. A. Gee, M. I. Ahmed, A. J. Duleba, L. Zhao, S. J. Gee, B. D. Hammock, and B. L. Lasley Triclocarban Enhances Testosterone Action: A New Type of Endocrine Disruptor? Endocrinology, March 1, 2008; 149(3): 1173 - 1179. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Plymate, K. Haugk, I. Coleman, L. Woodke, R. Vessella, P. Nelson, R. B. Montgomery, D. L. Ludwig, and J. D. Wu An Antibody Targeting the Type I Insulin-like Growth Factor Receptor Enhances the Castration-Induced Response in Androgen-Dependent Prostate Cancer Clin. Cancer Res., November 1, 2007; 13(21): 6429 - 6439. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zong, Y. Chi, Y. Wang, Y. Yang, L. Zhang, H. Chen, J. Jiang, Z. Li, Y. Hong, H. Wang, et al. Cyclin D3/CDK11p58 Complex Is Involved in the Repression of Androgen Receptor Mol. Cell. Biol., October 15, 2007; 27(20): 7125 - 7142. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-Y. Park, X. Yu, C. Ip, J. L. Mohler, P. N. Bogner, and Y.-M. Park Peroxiredoxin 1 Interacts with Androgen Receptor and Enhances Its Transactivation Cancer Res., October 1, 2007; 67(19): 9294 - 9303. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. L. Weigel and N. L. Moore Steroid Receptor Phosphorylation: A Key Modulator of Multiple Receptor Functions Mol. Endocrinol., October 1, 2007; 21(10): 2311 - 2319. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. K. Mukhopadhyay, B. Cinar, L. Mukhopadhyay, M. Lutchman, A. S. Ferdinand, J. Kim, L. W. K. Chung, R. M. Adam, S. K. Ray, A. B. Leiter, et al. The Zinc Finger Protein Ras-Responsive Element Binding Protein-1 Is a Coregulator of the Androgen Receptor: Implications for the Role of the Ras Pathway in Enhancing Androgenic Signaling in Prostate Cancer Mol. Endocrinol., September 1, 2007; 21(9): 2056 - 2070. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. T. Kesler, D. Gioeli, M. R. Conaway, M. J. Weber, and B. M. Paschal Subcellular Localization Modulates Activation Function 1 Domain Phosphorylation in the Androgen Receptor Mol. Endocrinol., September 1, 2007; 21(9): 2071 - 2084. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-S. Yang, H.-W. Xin, J. B. Kelley, A. Spencer, D. L. Brautigan, and B. M. Paschal Ligand Binding to the Androgen Receptor Induces Conformational Changes That Regulate Phosphatase Interactions Mol. Cell. Biol., May 1, 2007; 27(9): 3390 - 3404. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-M. Chiu, S.-H. Yeh, P.-J. Chen, T.-J. Kuo, C.-J. Chang, P.-J. Chen, W.-J. Yang, and D.-S. Chen Inaugural Article: Hepatitis B virus X protein enhances androgen receptor-responsive gene expression depending on androgen level PNAS, February 20, 2007; 104(8): 2571 - 2578. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kraus, D. Gioeli, T. Vomastek, V. Gordon, and M. J. Weber Receptor for Activated C Kinase 1 (RACK1) and Src Regulate the Tyrosine Phosphorylation and Function of the Androgen Receptor. Cancer Res., November 15, 2006; 66(22): 11047 - 11054. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chen, Y. Xu, X. Yuan, G. J. Bubley, and S. P. Balk Androgen receptor phosphorylation and stabilization in prostate cancer by cyclin-dependent kinase 1 PNAS, October 24, 2006; 103(43): 15969 - 15974. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-H. Ma, L. Xia, S. J. Desai, D. L. Boucher, Y. Guan, H.-M. Shih, X.-B. Shi, R. W. deVere White, H.-W. Chen, C. G. Tepper, et al. Male Germ Cell-Associated Kinase, a Male-Specific Kinase Regulated by Androgen, Is a Coactivator of Androgen Receptor in Prostate Cancer Cells. Cancer Res., September 1, 2006; 66(17): 8439 - 8447. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-Y. Park, Y.-J. Kim, A. C. Gao, J. L. Mohler, S. A. Onate, A. A. Hidalgo, C. Ip, E.-M. Park, S. Y. Yoon, and Y.-M. Park Hypoxia increases androgen receptor activity in prostate cancer cells. Cancer Res., May 15, 2006; 66(10): 5121 - 5129. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Li, M. Szabolcs, J. D. Terwilliger, and A. Efstratiadis Prostatic intraepithelial neoplasia and adenocarcinoma in mice expressing a probasin-Neu oncogenic transgene Carcinogenesis, May 1, 2006; 27(5): 1054 - 1067. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Pienta and D. Bradley Mechanisms underlying the development of androgen-independent prostate cancer. Clin. Cancer Res., March 15, 2006; 12(6): 1665 - 1671. [Full Text] [PDF] |
||||
![]() |
D. Gioeli, B. E. Black, V. Gordon, A. Spencer, C. T. Kesler, S. T. Eblen, B. M. Paschal, and M. J. Weber Stress Kinase Signaling Regulates Androgen Receptor Phosphorylation, Transcription, and Localization Mol. Endocrinol., March 1, 2006; 20(3): 503 - 515. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Taneja, S. Ha, N. K. Swenson, H. Y. Huang, P. Lee, J. Melamed, E. Shapiro, M. J. Garabedian, and S. K. Logan Cell-specific Regulation of Androgen Receptor Phosphorylation in Vivo J. Biol. Chem., December 9, 2005; 280(49): 40916 - 40924. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.-C. Wu, C. L. Smith, and B. W. O'Malley Transcriptional Regulation by Steroid Receptor Coactivator Phosphorylation Endocr. Rev., May 1, 2005; 26(3): 393 - 399. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Narayanan, D. P. Edwards, and N. L. Weigel Human Progesterone Receptor Displays Cell Cycle-Dependent Changes in Transcriptional Activity Mol. Cell. Biol., April 15, 2005; 25(8): 2885 - 2898. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.E. Clark, T.M. Errington, J.A. Smith, H.F. Frierson Jr., M.J. Weber, and D.A. Lannigan The Serine/Threonine Protein Kinase, p90 Ribosomal S6 Kinase, Is an Important Regulator of Prostate Cancer Cell Proliferation Cancer Res., April 15, 2005; 65(8): 3108 - 3116. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liu, S. Majumder, W. McCall, C. I. Sartor, J. L. Mohler, C. W. Gregory, H. S. Earp, and Y. E. Whang Inhibition of HER-2/neu Kinase Impairs Androgen Receptor Recruitment to the Androgen Responsive Enhancer Cancer Res., April 15, 2005; 65(8): 3404 - 3409. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Kasbohm, R. Guo, C. W. Yowell, G. Bagchi, P. Kelly, P. Arora, P. J. Casey, and Y. Daaka Androgen Receptor Activation by Gs Signaling in Prostate Cancer Cells J. Biol. Chem., March 25, 2005; 280(12): 11583 - 11589. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-S. Yang, M. J. Vitto, S. A. Busby, B. A. Garcia, C. T. Kesler, D. Gioeli, J. Shabanowitz, D. F. Hunt, K. Rundell, D. L. Brautigan, et al. Simian Virus 40 Small t Antigen Mediates Conformation-Dependent Transfer of Protein Phosphatase 2A onto the Androgen Receptor Mol. Cell. Biol., February 15, 2005; 25(4): 1298 - 1308. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Kim, L Jia, M R Stallcup, and G A Coetzee The role of protein kinase A pathway and cAMP responsive element-binding protein in androgen receptor-mediated transcription at the prostate-specific antigen locus J. Mol. Endocrinol., February 1, 2005; 34(1): 107 - 118. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Narayanan, A. A. Adigun, D. P. Edwards, and N. L. Weigel Cyclin-Dependent Kinase Activity Is Required for Progesterone Receptor Function: Novel Role for Cyclin A/Cdk2 as a Progesterone Receptor Coactivator Mol. Cell. Biol., January 1, 2005; 25(1): 264 - 277. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Umar, C. A. Berrevoets, N. M. Van, M. van Leeuwen, M. Verbiest, W. J. Kleijer, D. Dooijes, J. A. Grootegoed, S. L. S. Drop, and A. O. Brinkmann Functional Analysis of a Novel Androgen Receptor Mutation, Q902K, in an Individual with Partial Androgen Insensitivity J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 507 - 515. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. N. Papandreou and C. J. Logothetis Bortezomib as a Potential Treatment for Prostate Cancer Cancer Res., August 1, 2004; 64(15): 5036 - 5043. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. He, S. Bai, A. T. Hnat, R. I. Kalman, J. T. Minges, C. Patterson, and E. M. Wilson An Androgen Receptor NH2-terminal Conserved Motif Interacts with the COOH Terminus of the Hsp70-interacting Protein (CHIP) J. Biol. Chem., July 16, 2004; 279(29): 30643 - 30653. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fu, M. Rao, K. Wu, C. Wang, X. Zhang, M. Hessien, Y.-G. Yeung, D. Gioeli, M. J. Weber, and R. G. Pestell The Androgen Receptor Acetylation Site Regulates cAMP and AKT but Not ERK-induced Activity J. Biol. Chem., July 9, 2004; 279(28): 29436 - 29449. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Callewaert, G. Verrijdt, A. Haelens, and F. Claessens Differential Effect of Small Ubiquitin-Like Modifier (SUMO)-ylation of the Androgen Receptor in the Control of Cooperativity on Selective Versus Canonical Response Elements Mol. Endocrinol., June 1, 2004; 18(6): 1438 - 1449. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Liao, J. B. Thrasher, J. Holzbeierlein, S. Stanley, and B. Li Glycogen Synthase Kinase-3{beta} Activity Is Required for Androgen-Stimulated Gene Expression in Prostate Cancer Endocrinology, June 1, 2004; 145(6): 2941 - 2949. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Salas, J. Kim, F. Vakar-Lopez, A. L. Sabichi, P. Troncoso, G. Jenster, A. Kikuchi, S.-Y. Chen, L. Shemshedini, M. Suraokar, et al. Glycogen Synthase Kinase-3{beta} Is Involved in the Phosphorylation and Suppression of Androgen Receptor Activity J. Biol. Chem., April 30, 2004; 279(18): 19191 - 19200. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Black, M. J. Vitto, D. Gioeli, A. Spencer, N. Afshar, M. R. Conaway, M. J. Weber, and B. M. Paschal Transient, Ligand-Dependent Arrest of the Androgen Receptor in Subnuclear Foci Alters Phosphorylation and Coactivator Interactions Mol. Endocrinol., April 1, 2004; 18(4): 834 - 850. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Smith and B. W. O'Malley Coregulator Function: A Key to Understanding Tissue Specificity of Selective Receptor Modulators Endocr. Rev., February 1, 2004; 25(1): 45 - 71. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Daaka G Proteins in Cancer: The Prostate Cancer Paradigm Sci. Signal., January 20, 2004; 2004(216): re2 - re2. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Schrantz, J. d. S. Correia, B. Fowler, Q. Ge, Z. Sun, and G. M. Bokoch Mechanism of p21-activated Kinase 6-mediated Inhibition of Androgen Receptor Signaling J. Biol. Chem., January 16, 2004; 279(3): 1922 - 1931. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. V. Nantermet, J. Xu, Y. Yu, P. Hodor, D. Holder, S. Adamski, M. A. Gentile, D. B. Kimmel, S.-i. Harada, D. Gerhold, et al. Identification of Genetic Pathways Activated by the Androgen Receptor during the Induction of Proliferation in the Ventral Prostate Gland J. Biol. Chem., January 9, 2004; 279(2): 1310 - 1322. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-K. Lin, Y.-C. Hu, L. Yang, S. Altuwaijri, Y.-T. Chen, H.-Y. Kang, and C. Chang Suppression Versus Induction of Androgen Receptor Functions by the Phosphatidylinositol 3-Kinase/Akt Pathway in Prostate Cancer LNCaP Cells with Different Passage Numbers J. Biol. Chem., December 19, 2003; 278(51): 50902 - 50907. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Li, C. H. Ren, S. A. Tahir, C. Ren, and T. C. Thompson Caveolin-1 Maintains Activated Akt in Prostate Cancer Cells through Scaffolding Domain Binding Site Interactions with and Inhibition of Serine/Threonine Protein Phosphatases PP1 and PP2A Mol. Cell. Biol., December 15, 2003; 23(24): 9389 - 9404. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. LaFevre-Bernt and L. M. Ellerby Kennedy's Disease: PHOSPHORYLATION OF THE POLYGLUTAMINE-EXPANDED FORM OF ANDROGEN RECEPTOR REGULATES ITS CLEVAGE BY CASPASE-3 AND ENHANCES CELL DEATH J. Biol. Chem., September 12, 2003; 278(37): 34918 - 34924. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Lee and C. Chang Expression and Degradation of Androgen Receptor: Mechanism and Clinical Implication J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4043 - 4054. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Henrich, J. A. Smith, D. Kitt, T. M. Errington, B. Nguyen, A. M. Traish, and D. A. Lannigan Extracellular Signal-Regulated Kinase 7, a Regulator of Hormone-Dependent Estrogen Receptor Destruction Mol. Cell. Biol., September 1, 2003; 23(17): 5979 - 5988. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Petre-Draviam, S. L. Cook, C. J. Burd, T. W. Marshall, Y. B. Wetherill, and K. E. Knudsen Specificity of Cyclin D1 for Androgen Receptor Regulation Cancer Res., August 15, 2003; 63(16): 4903 - 4913. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-Z. Liu, H. Wang, and Z. Wang Identification of a Highly Conserved Domain in the Androgen Receptor That Suppresses the DNA-binding Domain-DNA Interactions J. Biol. Chem., April 18, 2003; 278(17): 14956 - 14960. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Bakin, D. Gioeli, R. A. Sikes, E. A. Bissonette, and M. J. Weber Constitutive Activation of the Ras/Mitogen-activated Protein Kinase Signaling Pathway Promotes Androgen Hypersensitivity in LNCaP Prostate Cancer Cells Cancer Res., April 15, 2003; 63(8): 1981 - 1989. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Tepavcevic, R. R. Hodges, D. Zoukhri, and D. A. Dartt Signal Transduction Pathways Used by EGF to Stimulate Protein Secretion in Rat Lacrimal Gland Invest. Ophthalmol. Vis. Sci., March 1, 2003; 44(3): 1075 - 1081. [Abstract] [Full Text] [PDF] |
||||
![]() |
|